期刊文献+

Liver regeneration biology:Implications for liver tumour therapies 被引量:2

下载PDF
导出
摘要 The liver has remarkable regenerative potential,with the capacity to regenerate after 75%hepatectomy in humans and up to 90%hepatectomy in some rodent models,enabling it to meet the challenge of diverse injury types,including physical trauma,infection,inflammatory processes,direct toxicity,and immunological insults.Current understanding of liver regeneration is based largely on animal research,historically in large animals,and more recently in rodents and zebrafish,which provide powerful genetic manipulation experimental tools.Whilst immensely valuable,these models have limitations in extrapolation to the human situation.In vitro models have evolved from 2-dimensional culture to complex 3 dimensional organoids,but also have shortcomings in replicating the complex hepatic micro-anatomical and physiological milieu.The process of liver regeneration is only partially understood and characterized by layers of complexity.Liver regeneration is triggered and controlled by a multitude of mitogens acting in autocrine,paracrine,and endocrine ways,with much redundancy and cross-talk between biochemical pathways.The regenerative response is variable,involving both hypertrophy and true proliferative hyperplasia,which is itself variable,including both cellular phenotypic fidelity and cellular trans-differentiation,according to the type of injury.Complex interactions occur between parenchymal and non-parenchymal cells,and regeneration is affected by the status of the liver parenchyma,with differences between healthy and diseased liver.Finally,the process of termination of liver regeneration is even less well understood than its triggers.The complexity of liver regeneration biology combined with limited understanding has restricted specific clinical interventions to enhance liver regeneration.Moreover,manipulating the fundamental biochemical pathways involved would require cautious assessment,for fear of unintended consequences.Nevertheless,current knowledge provides guiding principles for strategies to optimise liver regeneration potential.
出处 《World Journal of Clinical Oncology》 CAS 2021年第12期1101-1156,共56页 世界临床肿瘤学杂志(英文版)
  • 相关文献

参考文献6

二级参考文献321

  • 1Yan, Mao-Lin,Wang, Yao-Dong,Tian, Yi-Feng,Lai, Zhi-De,Yan, Lv-Nan.Inhibition of allogeneic T-cell response by Kupffer cells expressing indoleamine 2,3-dioxygenase[J].World Journal of Gastroenterology,2010,16(5):636-640. 被引量:6
  • 2Xiao-WeiLiu,Fang-GenLu,Guang-SenZhang,Xiao-PingWu,YuYou,Chun-HuiOuyang,Dong-YeYang.Proteomics to display tissue repair opposing injury response to LPS-induced liver injury[J].World Journal of Gastroenterology,2004,10(18):2701-2705. 被引量:5
  • 3Hong-Sheng Wang,Nobuhiro Ohkohchi,Yoshitaka Enomoto,Masahiro Usuda,Shigehito Miyagi,Takeshi Asakura,Hiroo Masuoka,Takashi Aiso,Keisuke Fukushima,Tomohiro Narita,Hideyuki Yamaya,Atsushi Nakamura,Satoshi Sekiguchi,Naoki Kawagishi,Akira Sato,Susumu Satomi.Excessive portal flow causes graft failure in extremely small-for-size liver transplantation in pigs[J].World Journal of Gastroenterology,2005,11(44):6954-6959. 被引量:8
  • 4[93]Cariou B,van Harmelen K,Duran-Sandoval D,van Dijk TH,Grefhorst A,Abdelkarim M,Caron S,Torpier G,Fruchart JC,Gonzalez FJ,Kuipers F,Staels B.The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.J Biol Chem 2006; 281:11039-11049
  • 5[94]Eromm H,Eschler A,Tollner D,Canzler H,Schmidt FW.[In vivo dissolving of gall-stones:the effect of chenodeoxycholic acid.(author's transl)] Dtsch ivied Wochenschr 1975; 100:1619-1624
  • 6[95]Camarri E,Fici F,Marcolongo R.Influence of chenodeoxycholic acid on serum triglycerides in patients with primary hypertriglyceridemia.Int J Clin Pharmacol Biopharm 1978; 16:523-526
  • 7[96]Carulli N,Ponz de Leon M,Podda M,Zuin M,Strata A,Frigerio G,Digrisolo A.Chenodeoxycholic acid and ursodeoxycholic acid effects in endogenous hypertriglyceridemias.A controlled double-blind trial.J Clin Pharmacol 1981; 21:436-442
  • 8[97]Crouse JR 3rd.Hypertriglyceridemia:a contraindication to the use of bile acid binding resins.Am J Med 1987; 83:243-248
  • 9[98]Beil U,Crouse JR,Einarsson K,Grundy SM.Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides.Metabolism 1982; 31:438-444
  • 10[99]Lambert G,Amar MJ,Guo G,Brewer HB Jr,Gonzalez FJ,Sinai CJ.The farnesoid X-receptor is an essential regulator of cholesterol homeostasis.J Biol Chem 2003; 278:2563-2570

共引文献118

同被引文献14

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部